title: Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
abstract: Bullous pemphigoid (BP) is a common autoimmune blistering disease in the adult population, but extremely rare in the pediatric population. Childhood BP usually has a favorable prognosis and responds well to topical and oral steroids. However, for patients that do not respond to corticosteroids, therapeutic alternatives are scarce. We report a case of a toddler with recalcitrant BP who was successfully treated with mycophenolate mofetil (MMF).
authors.forename: Lucia
authors.initials: L
authors.lastname: Seminario-Vidal
authors.forename: Naveed
authors.initials: N
authors.lastname: Sami
authors.forename: Jonathan
authors.initials: J
authors.lastname: Miller
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham. amy.theos@chsys.org.
authors.forename: Amy
authors.initials: A
authors.lastname: Theos
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004351:Drug Resistance; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007223:Infant; D016131:Lymphocyte Subsets / Q000187:drug effects; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy; D012074:Remission Induction; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000209:etiology; D015163:Superinfection / Q000188:drug therapy / Q000209:etiology; D014581:Urticaria / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D002981:Clindamycin; D003622:Dapsone; D009173:Mycophenolic Acid; D011241:Prednisone